ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
GentiBio, Forge Biologics Ink Development and Manufacturing Agreement
July 19, 2021GentiBio and Forge Biologics have entered a development and manufacturing partnership to advance GentiBio’s immune tolerance platform. -
Forge Biologics Announces Multiple FDA Designations for Krabbe Disease Therapeutic
February 19, 2021Forge Biologics announced the U.S. Food and Drug Administration (FDA) has granted Fast Track, Orphan Drug, and Rare Pediatric Disease (RPD) designations to FBX-101 for the treatment of patients with Krabbe disease. -
Forge Receives Notice of Allowance from USPTO Covering Novel Chemistry Targeting LpxC
August 15, 2019Forge Therapeutics announced the United States Patent and Trademark Office (USPTO) has issued a notice of allowance for its patent application directed to compositions of matter and methods of use of certain 'non-hydroxamate' inhibitors of LpxC for the tr
Pharma Sources Insight January 2025
